Resveratrol via activation of AMPK lowers blood pressure in DOCA-salt hypertensive mice

References

• Chobanian AV. Mixed messages on blood pressure goals. Hypertension 2011;57:1039–40
   PubMed Web of Science ®Google Scholar
• Wang S, Liang B, Viollet B, Zou MH. Inhibition of the amp-activated protein kinase-alpha2 accentuates agonist-induced vascular smooth muscle contraction and high blood pressure in mice. Hypertension 2011;57:1010–17
   PubMed Web of Science ®Google Scholar
• Signorelli P, Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 2005;16:449–66
   PubMed Web of Science ®Google Scholar
• Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218–20
   PubMed Web of Science ®Google Scholar
• Hamza SM, Dyck JR. Systemic and renal oxidative stress in the pathogenesis of hypertension: modulation of long-term control of arterial blood pressure by resveratrol. Front Physiol 2014;5:292
   PubMed Web of Science ®Google Scholar
• Kanamori H, Takemura G, Goto K, et al. Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating amp kinase pathway. Am J Pathol 2013;182:701–13
   PubMed Web of Science ®Google Scholar
• Kemp BE, Stapleton D, Campbell DJ, et al. Amp-activated protein kinase, super metabolic regulator. Biochem Soc Trans 2003;31:162–8
   PubMed Web of Science ®Google Scholar
• Winder WW, Hardie DG. Amp-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 1999;277:E1–10
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang C, Zhang M, et al. Activation of amp-activated protein kinase alpha2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo. Nat Med 2012;18:902–10
   PubMed Web of Science ®Google Scholar
• Hawley SA, Selbert MA, Goldstein EG, et al. 5′-Amp activates the amp-activated protein kinase cascade, and ca2+/calmodulin activates the calmodulin-dependent protein kinase i cascade, via three independent mechanisms. J Biol Chem 1995;270:27186–91
   PubMed Web of Science ®Google Scholar
• Wang S, Xu J, Song P, et al. In vivo activation of amp-activated protein kinase attenuates diabetes-enhanced degradation of gtp cyclohydrolase i. Diabetes 2009;58:1893–901
   PubMed Web of Science ®Google Scholar
• Du YH, Guan YY, Alp NJ, et al. Endothelium-specific gtp cyclohydrolase i overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension. Circulation 2008;117:1045–54
   PubMed Web of Science ®Google Scholar
• Wang S, Peng Q, Zhang J, Liu L. Na+/h+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain. Cardiovasc Res 2008;80:255–62
   PubMed Web of Science ®Google Scholar
• Liang B, Wang S, Wang Q, et al. Aberrant endoplasmic reticulum stress in vascular smooth muscle increases vascular contractility and blood pressure in mice deficient of amp-activated protein kinase-alpha2 in vivo. Arterioscler Thromb Vasc Biol 2013;33:595–604
   PubMed Web of Science ®Google Scholar
• Wang S, Xu J, Song P, et al. Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure. Hypertension 2008;52:484–90
   PubMed Web of Science ®Google Scholar
• Cao X, Luo T, Luo X, Tang Z. Resveratrol prevents angii-induced hypertension via ampk activation and rhoa/rock suppression in mice. Hypertens Res: Official J Jpn Soc Hyperten 2014;37:803–10
   PubMed Web of Science ®Google Scholar
• Foretz M, Guihard S, Leclerc J, et al. Maintenance of red blood cell integrity by amp-activated protein kinase alpha1 catalytic subunit. FEBS Lett 2010;584:3667–71
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang M, Liang B, et al. Ampkalpha2 deletion causes aberrant expression and activation of nad(p)h oxidase and consequent endothelial dysfunction in vivo: role of 26s proteasomes. Circ Res 2009;106:1117–28
   Web of Science ®Google Scholar
• Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin ii: modulated by g proteins, kinases, and myosin phosphatase. Physiol Rev 2003;83:1325–58
   PubMed Web of Science ®Google Scholar
• Chen NX, Chen X, O'Neill KD, et al. Rhoa/rho kinase (rock) alters fetuin-a uptake and regulates calcification in bovine vascular smooth muscle cells (bvsmc). Am J Physiol: Renal Physiol 2010;299:F674–80
   Google Scholar
• Cal C, Garban H, Jazirehi A, et al. Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities. Curr Med Chem: Anti-Cancer Agents 2003;3:77–93
   PubMedGoogle Scholar
• Neves AR, Lucio M, Lima JL, Reis S. Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Curr Med Chem 2012;19:1663–81
   PubMed Web of Science ®Google Scholar
• Kiselev KV. Perspectives for production and application of resveratrol. Appl Microbiol Biotechnol 2011;90:417–25
   PubMed Web of Science ®Google Scholar
• Tomayko EJ, Cachia AJ, Chung HR, Wilund KR. Resveratrol supplementation reduces aortic atherosclerosis and calcification and attenuates loss of aerobic capacity in a mouse model of uremia. J Med Food 2014;17:278–83
   PubMed Web of Science ®Google Scholar
• Yemane H, Busauskas M, Burris SK, Knuepfer MM. Neurohumoral mechanisms in deoxycorticosterone acetate (doca)-salt hypertension in rats. Exp Physiol 2010;95:51–5
   PubMed Web of Science ®Google Scholar
• Bae YM, Sung DJ, Noh HJ, et al. Serotonin-induced ion channel modulations in mesenteric artery myocytes from normotensive and doca-salt hypertensive rats. J Smooth Muscle Res = Nihon Heikatsukin Gakkai kikanshi 2007;43:85–97
   PubMedGoogle Scholar
• Petrovski G, Gurusamy N, Das DK. Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci 2011;1215:22–33
   PubMed Web of Science ®Google Scholar
• Fujita T. Mechanism of salt-sensitive hypertension: focus on adrenal and sympathetic nervous systems. J Am Soc Nephrol 2014;25:1148–55
   PubMed Web of Science ®Google Scholar
• Wenceslau CF, Rossoni LV. Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of na+k+-atpase/csrc pathway. J Hypertens 2014;32:542–54
   PubMed Web of Science ®Google Scholar
• Rodriguez-Iturbe B, Vaziri ND. Salt-sensitive hypertension – update on novel findings. Nephrol, Dial, Transplant: Off Pub Eur Dial Transpl Assoc – Eur Renal Assoc 2007;22:992–5
   PubMed Web of Science ®Google Scholar